Clindamycin 10 MG/ML Topical Solution — RxCUI 309333
RxNorm drug concept · Semantic clinical drug
RxCUI 309333
Semantic clinical drug · SCD
● Current RxNorm concept 34 FDA products
50 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI309333
Official nameClindamycin 10 MG/ML Topical Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asclindamycin 1 % Topical Solution; clindamycin phosphate 1 % Topical Solution; clindamycin (as clindamycin phosphate) 1 % Topical Solution
FDA products mapped34
Package NDCs mapped50
Reported Medicaid activity (SDUD)868,111 prescriptions · 50 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Clindamycin Topical: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It treats bacterial vaginosis, a vaginal infection caused by an imbalance of bacteria. It can be used in non-pregnant women and in pregnant women in the second and third trimester....
- It's best not to. The cream contains mineral oil that can weaken latex condoms and diaphragms. Avoid them during treatment and for 5 days afterward, because they may not prevent pr...
- Some women get a vaginal yeast infection or vaginal irritation. These were the most common in trials. Let your prescriber know if symptoms bother you.
- Call if you get diarrhea, especially if it is bloody or doesn't go away. Antibiotics can allow a harmful bowel germ to overgrow, and this can happen even weeks after treatment. Als...
🕸️ Concept Web — How Clindamycin 10 MG/ML Topical Solution Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Clindamycin 10 MG/ML Topical Solution
RxCUI 309333 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Clindamycin
2582IN
-
Clindamycin
-
Dose forms 4
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Clindamycin Topical Solution
377481SCDF -
Clindamycin Topical Product
1152788SCDG -
Topical Solution
316986DF -
Topical Product
1151122DFG
-
Clindamycin Topical Solution
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Clindamycin 10 MG/ML
343113SCDC
-
Clindamycin 10 MG/ML
Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Clindamycin 10 MG/ML
SCDC · 343113 -
Clindamycin Topical Solution
SCDF · 377481 -
Clindamycin Topical Product
SCDG · 1152788
📦 FDA Products & Package NDCs
34 products · 50 package NDCs
50 package NDCs map to RxCUI 309333 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00009-3329-01 | 1 BOTTLE in 1 CARTON (0009-3329-01) / 60 mL in 1 BOTTLE | Cleocin T | Pharmacia & Upjohn Company LLC | 1989-05-31 |
| 00168-0201-30 | 1 BOTTLE in 1 CARTON (0168-0201-30) / 30 mL in 1 BOTTLE | clindamycin phosphate | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | 1997-06-05 |
| 00168-0201-60 | 1 BOTTLE in 1 CARTON (0168-0201-60) / 60 mL in 1 BOTTLE | clindamycin phosphate | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | 1997-06-05 |
| 00168-0202-30 | 1 TUBE in 1 CARTON (0168-0202-30) / 30 g in 1 TUBE | clindamycin phosphate | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | 2000-01-28 |
| 00168-0202-60 | 1 TUBE in 1 CARTON (0168-0202-60) / 60 g in 1 TUBE | clindamycin phosphate | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | 2000-01-28 |
| 00168-0203-60 | 1 BOTTLE in 1 CARTON (0168-0203-60) / 60 mL in 1 BOTTLE | clindamycin phosphate | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | 2002-01-31 |
| 00378-8688-54 | 1 KIT in 1 CARTON (0378-8688-54) * 10 g in 1 BOTTLE, PLAST... | Clindamycin Phosphate and Benzoyl Peroxide | Mylan Pharmaceuticals Inc. | 2009-08-25 |
| 16571-0256-60 | 60 APPLICATOR in 1 JAR (16571-256-60) / 1 mL in 1 APPLICATO... | Clindamycin Phosphate | Rising Pharma Holdings, Inc. | 2026-03-23 |
| 16571-0256-69 | 69 APPLICATOR in 1 JAR (16571-256-69) / 1 mL in 1 APPLICATO... | Clindamycin Phosphate | Rising Pharma Holdings, Inc. | 2026-03-23 |
| 21922-0002-01 | 1 BOTTLE in 1 CARTON (21922-002-01) / 60 mL in 1 BOTTLE | Clindamycin Phoaphate Topical Solution USP, 1% | Encube Ethicals, Inc. | 2019-03-04 |
| 21922-0002-21 | 1 BOTTLE in 1 CARTON (21922-002-21) / 30 mL in 1 BOTTLE | Clindamycin Phoaphate Topical Solution USP, 1% | Encube Ethicals, Inc. | 2020-07-13 |
| 43538-0170-69 | 69 APPLICATOR in 1 JAR (43538-170-69) / 1 mL in 1 APPLICATO... | Clindacin P | Eurofarma, Inc. | 2026-06-15 |
| 43538-0170-99 | 12 PACKET in 1 CARTON (43538-170-99) / 1 mL in 1 PACKET | Clindacin P | Eurofarma, Inc. | 2026-06-15 |
| 45802-0263-37 | 60 APPLICATOR in 1 JAR (45802-263-37) / 1 mL in 1 APPLICATO... | Clindamycin Phosphate | Padagis Israel Pharmaceuticals Ltd | 2006-05-31 |
| 45802-0507-04 | 1 KIT in 1 CARTON (45802-507-04) * .6 g in 1 VIAL * 39.4... | clindamycin and benzoyl peroxide | Padagis Israel Pharmaceuticals Ltd | 2016-04-26 |
| 45802-0562-01 | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (45802-562-01) / 30 m... | Clindamycin Phosphate | Padagis Israel Pharmaceuticals Ltd | 2013-09-17 |
| 45802-0562-02 | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (45802-562-02) / 60 m... | Clindamycin Phosphate | Padagis Israel Pharmaceuticals Ltd | 2013-09-17 |
| 45802-0562-30 | 30 mL in 1 BOTTLE, WITH APPLICATOR (45802-562-30) | Clindamycin Phosphate | Padagis Israel Pharmaceuticals Ltd | 2026-04-28 |
| 45802-0562-60 | 60 mL in 1 BOTTLE, WITH APPLICATOR (45802-562-60) | Clindamycin Phosphate | Padagis Israel Pharmaceuticals Ltd | 2026-04-28 |
| 50090-1932-00 | 60 APPLICATOR in 1 JAR (50090-1932-0) / 1 mL in 1 APPLICATO... | Clindamycin Phosphate | A-S Medication Solutions | 2015-07-16 |
| 50090-2611-00 | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (50090-2611-0) / 60 m... | Clindamycin Phosphate | A-S Medication Solutions | 2016-11-10 |
| 50090-6592-00 | 1 BOTTLE in 1 CARTON (50090-6592-0) / 60 mL in 1 BOTTLE | Clindamycin Phoaphate Topical USP, 1% | A-S Medication Solutions | 2023-08-15 |
| 50090-6593-00 | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (50090-6593-0) / 60 m... | Clindamycin Phosphate | A-S Medication Solutions | 2023-08-17 |
| 51672-1381-02 | 1 KIT in 1 CARTON (51672-1381-2) * 5 g in 1 BOTTLE, PLASTI... | Clindamycin Phosphate and Benzoyl Peroxide | Sun Pharmaceutical Industries, Inc. | 2018-05-25 |
| 51672-1381-04 | 1 KIT in 1 CARTON (51672-1381-4) * 10 g in 1 BOTTLE, PLAST... | Clindamycin Phosphate and Benzoyl Peroxide | Sun Pharmaceutical Industries, Inc. | 2018-05-25 |
| 51672-1381-05 | 1 KIT in 1 CARTON (51672-1381-5) * 7 g in 1 BOTTLE, PLASTI... | Clindamycin Phosphate and Benzoyl Peroxide | Sun Pharmaceutical Industries, Inc. | 2020-01-21 |
| 51672-1381-06 | 1 KIT in 1 CARTON (51672-1381-6) * 10 g in 1 BOTTLE, PLAST... | Clindamycin Phosphate and Benzoyl Peroxide | Sun Pharmaceutical Industries, Inc. | 2020-01-21 |
| 51672-4081-03 | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (51672-4081-3) / 30 m... | Clindamycin Phosphate | Sun Pharmaceutical Industries, Inc. | 2004-03-31 |
| 51672-4081-04 | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (51672-4081-4) / 60 m... | Clindamycin Phosphate | Sun Pharmaceutical Industries, Inc. | 2004-03-31 |
| 59762-3743-01 | 1 TUBE in 1 CARTON (59762-3743-1) / 30 g in 1 TUBE | clindamycin phosphate | Mylan Pharmaceuticals Inc. | 1987-01-07 |
| 59762-3743-02 | 1 TUBE in 1 CARTON (59762-3743-2) / 60 g in 1 TUBE | clindamycin phosphate | Mylan Pharmaceuticals Inc. | 1987-01-07 |
| 59762-3744-01 | 1 BOTTLE in 1 CARTON (59762-3744-1) / 60 mL in 1 BOTTLE | clindamycin phosphate | Mylan Pharmaceuticals Inc. | 1989-05-31 |
| 62135-0478-30 | 30 mL in 1 BOTTLE, WITH APPLICATOR (62135-478-30) | Clindamycin Phosphate | Chartwell RX, LLC | 2025-08-28 |
| 62135-0478-60 | 60 mL in 1 BOTTLE, WITH APPLICATOR (62135-478-60) | Clindamycin Phosphate | Chartwell RX, LLC | 2025-08-28 |
| 63629-8633-01 | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (63629-8633-1) / 30 m... | Clindamycin Phosphate | Bryant Ranch Prepack | 2013-09-17 |
| 63629-8634-01 | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (63629-8634-1) / 60 m... | Clindamycin Phosphate | Bryant Ranch Prepack | 2013-09-17 |
| 68788-7990-06 | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (68788-7990-6) / 60 m... | Clindamycin Phosphate | Preferred Pharmaceuticals Inc | 2021-08-06 |
| 70771-1414-02 | 1 BOTTLE in 1 CARTON (70771-1414-2) / 30 mL in 1 BOTTLE | Clindamycin phosphate | Zydus Lifesciences Limited | 2019-01-03 |
| 70771-1414-03 | 1 BOTTLE in 1 CARTON (70771-1414-3) / 60 mL in 1 BOTTLE | Clindamycin phosphate | Zydus Lifesciences Limited | 2019-01-03 |
| 71335-2861-01 | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (71335-2861-1) / 30 m... | Clindamycin Phosphate | Bryant Ranch Prepack | 2025-10-24 |
| 71335-2863-01 | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (71335-2863-1) / 60 m... | Clindamycin Phosphate | Bryant Ranch Prepack | 2025-10-24 |
| 72162-1418-03 | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (72162-1418-3) / 30 m... | Clindamycin Phosphate | Bryant Ranch Prepack | 2013-09-17 |
| 72162-1418-06 | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (72162-1418-6) / 60 m... | Clindamycin Phosphate | Bryant Ranch Prepack | 2013-09-17 |
| 72319-0696-60 | 60 APPLICATOR in 1 JAR (72319-696-60) / 1 mL in 1 APPLICATO... | Clindamycin phosphate | i3 Pharmaceuticals, LLC | 2025-06-16 |
| 72578-0084-02 | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (72578-084-02) / 30 m... | Clindamycin Phosphate | Viona Pharmaceuticals Inc | 2020-06-15 |
| 72578-0084-03 | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (72578-084-03) / 60 m... | Clindamycin Phosphate | Viona Pharmaceuticals Inc | 2020-06-15 |
| 72603-0321-01 | 1 BOTTLE in 1 CARTON (72603-321-01) / 30 mL in 1 BOTTLE | Clindamycin Phoaphate Topical Solution USP, 1% | Northstar Rx LLC | 2024-11-14 |
| 72603-0321-02 | 1 BOTTLE in 1 CARTON (72603-321-02) / 60 mL in 1 BOTTLE | Clindamycin Phoaphate Topical Solution USP, 1% | Northstar Rx LLC | 2024-11-14 |
| 80005-0131-09 | 60 APPLICATOR in 1 JAR (80005-131-09) / 1 mL in 1 APPLICATO... | Clindamycin Phosphate | Carnegie Pharmaceuticals, LLC | 2025-06-16 |
| 80005-0131-38 | 69 APPLICATOR in 1 JAR (80005-131-38) / 1 mL in 1 APPLICATO... | Clindamycin Phosphate | Carnegie Pharmaceuticals, LLC | 2025-12-15 |
Observed labelers:
Bryant Ranch Prepack (6) ·
Padagis Israel Pharmaceuticals Ltd (6) ·
Sun Pharmaceutical Industries, Inc. (6) ·
E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC (5) ·
A-S Medication Solutions (4) ·
Mylan Pharmaceuticals Inc. (4)
· +11 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.